Michael Klichinsky

Company: Carisma Therapeutics

Job title: Chief Scientific Officer

Seminars:

Reprogramming Myeloid Cells for Cancer: CAR-M from Ex Vivo to In Vivo 3:00 pm

Targeting macrophages with CARs for solid tumors Investigating pre-clinical and clinical data with ex vivo CAR-M cell therapies Describing our in vivo CAR-M platform that is being developed in partnership with ModernaRead more

day: Conference Day One